📑Isikukaitsevahendid
Procurement process summary
This process is to purchase Isikukaitsevahendid.
This contract was awarded by 🇪🇪 Kaitseliit for an amount of EUR 70,200 to 1 supplier. It was published on 2022-04-08 through direct
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇪 Kaitseliit Buying unitnot reported Publication date2022-04-08 Contest statusnot reported DescriptionKaitsevaele ja Kaitseliidule esmaste isikukaitsevahendite hankimiseksAwards
This award was granted to Globalex Pharma OÜ by Kaitseliit for an amount of EUR 70,200. The procurement process was conducted through direct for the category of goods. The award was granted on 2020-03-27. This is award number 4.
This contract has multiple awards. This is award number 4. View other awards for this contract
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇪🇪 Globalex Pharma OÜ | EUR 70,200 | 2020-03-27 | 4 |
Market context and opportunities
The execution of this contract allows the entity Kaitseliit to fulfill its public service objectives efficiently.
The direct purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberEE_ocds-70d2nz-ce69c321-276b-433b-aeef-85ac6feff80a-award-4Publication date2022-04-08Contract datenot reportedAward date2020-03-27CategoriesgoodsPurchase modalitydirectMethod detailspt_award_contract_without_callStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
